| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Apr 03, 2019 | Option Exercise | $156.68 | 1,084 | 169,841 | 16,941 | Apr 05, 2019, 12:01 PM | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Feb 12, 2019 | Option Exercise | $146.59 | 654 | 95,870 | 15,601 | Feb 14, 2019, 04:08 PM | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Feb 11, 2019 | Option Exercise | $144.29 | 1,973 | 284,684 | 14,792 | Feb 13, 2019, 11:55 AM | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Feb 07, 2019 | Option Exercise | $147.46 | 556 | 81,988 | 10,665 | Feb 11, 2019, 07:59 PM | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Feb 09, 2018 | Option Exercise | $168.08 | 2,132 | 358,347 | 9,398 | Feb 13, 2018, 02:08 PM | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Feb 07, 2018 | Option Exercise | $169.66 | 560 | 95,010 | 5,430 | Feb 09, 2018, 04:11 PM | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | Ratliff John D | CEO, Covance Drug Development | Feb 09, 2017 | Option Exercise | $133.83 | 2,013 | 269,400 | 4,127 | Feb 13, 2017, 02:28 PM | |
| Q | Quintiles Transnational Holdings Inc. | Ratliff John D | President and COO | Nov 18, 2013 | Option Exercise | $6.31 | 115,000 | 726,150 | 115,000 | Nov 19, 2013, 04:58 PM | |
| Q | Quintiles Transnational Holdings Inc. | Ratliff John D | President and COO | Nov 18, 2013 | Sale | $42.55 | 97,140 | 4,133,307 | 0 | Nov 19, 2013, 04:58 PM | |
| Q | Quintiles Transnational Holdings Inc. | Ratliff John D | President and COO | Nov 18, 2013 | Sale | $42.55 | 115,000 | 4,893,250 | 0 | Nov 19, 2013, 04:58 PM |
Menu